Full-Time

Validation Engineer II

Aiq

Posted on 3/19/2025

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$70k - $110k/yr

+ Short-term Incentives + Long-term Incentives + 401(k) Plan + Tuition Reimbursement + Paid Volunteer Time Off + Well-being Benefits

Mid

Lexington, MA, USA

This is a hybrid position located in Lexington, MA.

Category
QA & Testing
Quality Assurance
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Takeda referral from your network.

đź’ˇ

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Minimum BS or BA. Engineering or Science; advanced degree would be ideal; and other job-related experience.
  • 3+ years related experience in biopharmaceutical manufacturing environment validation, operations, engineering, or any combination thereof.
  • Experience in Pharmaceuticals or Life Sciences industry would be ideal.
  • Experience working in GxP laboratory or with analytical instruments would be ideal.
  • Knowledge of computer systems and software validation would be ideal.
  • Good communication and interpersonal skills. Able to clearly and concisely communicate with colleagues and stakeholders.
  • Basic investigation techniques to determine true root cause and resolve protocol discrepancies.
  • Familiarity with following tools and processes like TrackWise – CAPA, Deviation, Change Control, Veeva – Document Workflows, MS Office.
  • Conducts work in compliance with cGMPs, safety, and regulatory requirements.
Responsibilities
  • You will work with stakeholders to understand end user requirements and implement approved solutions.
  • You will stay informed about technology trends in the market and evaluate for potential value to the company.
  • You will execute and deliver tasks that are part of the Quality and Lab of the Future roadmap and existing QC portfolio.
  • You will work with project teams (Lab Systems, QC, and QA) during project kick-off and planning to ensure appropriate tasks are accounted for as defined in local and global SOPs.
  • You will create and update formal and informal department work instructions, tools, and job aids.
  • Identify areas of improvement and propose solutions to senior staff.
  • You will execute qualification of new and upgraded systems with oversight from senior staff.
  • You will create lifecycle documentation including System Classifications, Qualification Plans, User Requirements Specifications (URS), Functional Risk Assessments (FRA), Installation and Operational Qualifications (IOQ), Trace Matrices, and Periodic Review Reports.
  • You will partner with Quality Lab Systems personnel during qualification efforts to ensure optimum operational performance of delivered solutions.
  • You will provide support during FDA/Regulatory Authority Inspections and Readiness.
  • Participate in other QC activities as assigned on various initiatives and/or quality events.
  • Determine qualification and testing approach in accordance with Takeda policies and procedures.
  • Collaborate with cross-functional team members and subject matter experts to meet project objectives.
  • Escalate roadblocks, project delays, and quality issues to project managers and senior staff for resolution.
  • Advise internal QC system and process owners on adherence to Takeda policies and requirements. Consult and coordinate with internal application administrators or system owners to complete analytical instrument lifecycle deliverables. Coordinate with external vendors during setup, installation, maintenance, and troubleshooting of laboratory analytical instruments.
  • Advise project managers on execution of analytical instrument lifecycle activities.
Desired Qualifications
  • Experience in Pharmaceuticals or Life Sciences industry would be ideal.
  • Experience working in GxP laboratory or with analytical instruments would be ideal.
  • Knowledge of computer systems and software validation would be ideal.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized in all operations.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

INACTIVE